Leading Companies - Biomarkers Industry

Jul, 2023 - by CMI

Leading Companies - Biomarkers Industry

Any molecule that provides information about one's health can be a biomarker, including DNA, proteins, and hormones. They can be grouped according to a number of criteria, including characteristics like imaging biomarkers or molecular biomarkers. Over the course of the forecast period, an increase in R&D projects aimed at enhancing the efficacy of biomarker-based tests and assays is anticipated to fuel market expansion.

The Global Biomarkers Market is estimated to be valued at US$ 55.59 Bn in 2022 and is expected to exhibit a CAGR of 13.6% over the forecast period (2022-2030).

Major Players in the Biomarkers Industry:

1. Agilent Technologies, Inc.

Agilent Technologies, Inc. was founded in 19999 and it’s headquarter in Santa Clara, California, United States.The Company operates in 100+ countries. In 2020 announced the launch of the Biomarker Pathologist Training Program,

2. F. Hoffmann-La Roche Ltd.,

 F. Hoffmann-La Roche Ltd., was launch in 1896. And its headquarter located in Basel, Switzerland. It work in more than 110 country in world.In 2021 F. Hoffmann-La Roche Ltd. (Switzerland) launched Elecsys Anti-p53 immunoassay to aid the diagnosis of various types of cancers

3. Acobiom

Acobiom was launch in 1999 and it’s headquarter located in GRABELS FRANCE.it operate over 140 country.

4. Apis Assay Technologies Ltd

Apis Assay Technologies Ltd was launch in 2018 and it’s headquarter located in Manchester, United Kingdom.it operate over 10 country.

5. Eagle Biosciences, Inc

Eagle Biosciences, Inc founded in 2008, with its headquarters in Amherst, New Hampshire, United States .With businesses in over 19 countries.

6. Beckman Coulter, Inc

Beckman Coulter, Inc was launch 1935 and its headquarter Brea, California, United States ‎. it operate over 65 country.

7. Quanterix

Quanterix founded in 2007, with its headquarters in Middlesex Turnpike, United States .With businesses in over 35countries. In 2022, Quanterix announced new agreements with Lilly to advance Alzheimer's disease diagnosis and treatment; the agreements provide

*Definition- Biomarkers are molecules that are used to diagnose diseases as they show whether a bodily process is normal or abnormal. Biomarkers can be any molecules, including Deoxyribonucleic Acid (DNA), proteins, or hormones, that provide information about one's health

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.